{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T17:08:21Z","timestamp":1754154501436,"version":"3.41.2"},"reference-count":125,"publisher":"Elsevier","isbn-type":[{"type":"print","value":"9780323853231"}],"license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1016\/bs.pmbts.2021.01.021","type":"book-chapter","created":{"date-parts":[[2021,2,22]],"date-time":"2021-02-22T21:10:05Z","timestamp":1614028205000},"page":"289-308","source":"Crossref","is-referenced-by-count":8,"title":["Genome editing in cardiovascular diseases"],"prefix":"10.1016","member":"78","reference":[{"key":"10.1016\/bs.pmbts.2021.01.021_bb0010","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1007\/s11427-016-0192-5","article-title":"A novel RNA-guided RNA-targeting CRISPR tool","volume":"59","author":"Zhang","year":"2016","journal-title":"Sci China Life Sci"},{"key":"10.1016\/bs.pmbts.2021.01.021_bb0015","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s00239-004-0046-3","article-title":"Intervening sequences of regularly spaced prokaryotic repeats derive from foreign genetic elements","volume":"60","author":"Mojica","year":"2005","journal-title":"J Mol Evol"},{"key":"10.1016\/bs.pmbts.2021.01.021_bb0020","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1099\/mic.0.27437-0","article-title":"CRISPR elements in Yersinia pestis acquire new repeats by preferential uptake of bacteriophage DNA, and provide additional tools for evolutionary studies","volume":"151","author":"Pourcel","year":"2005","journal-title":"Microbiology"},{"key":"10.1016\/bs.pmbts.2021.01.021_bb9000","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1231143","article-title":"Multiplex genome engineering using CRISPR\/Cas systems","volume":"339","author":"Cong","year":"2013","journal-title":"Science"},{"key":"10.1016\/bs.pmbts.2021.01.021_bb0025","series-title":"Precision Medicine for Investigators, Practitioners and Providers","first-page":"59","article-title":"CRISPR technology for genome editing","author":"Bhattacharjee","year":"2019"},{"issue":"10","key":"10.1016\/bs.pmbts.2021.01.021_bb0030","first-page":"293","article-title":"CRISPR\/Cas-9 system: magnificent tool for genome editing","volume":"3","author":"Vasdev","year":"2017","journal-title":"Int J Biotechnol Bioeng"},{"key":"10.1016\/bs.pmbts.2021.01.021_bb0035","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1007\/s11427-016-0358-3","article-title":"From the first human gene-editing to the birth of three- parent baby","volume":"59","author":"Zhang","year":"2016","journal-title":"Sci China Life Sci"},{"issue":"5 Pt B","key":"10.1016\/bs.pmbts.2021.01.021_bb0040","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.jmb.2015.10.014","article-title":"Origins of programmable nucleases for genome engineering","volume":"428","author":"Chandrasegaran","year":"2016","journal-title":"J Mol Biol"},{"issue":"6","key":"10.1016\/bs.pmbts.2021.01.021_bb0045","doi-asserted-by":"crossref","first-page":"1262e1278","DOI":"10.1016\/j.cell.2014.05.010","article-title":"Development and applications of CRISPR-Cas9 for genome engineering","volume":"157","author":"Hsu","year":"2014","journal-title":"Cell"},{"key":"10.1016\/bs.pmbts.2021.01.021_bb0050","first-page":"191","article-title":"Non-homologous DNA end joining and alternative pathways to double-strand break repair","volume":"19","author":"Chang","year":"2017","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/bs.pmbts.2021.01.021_bb0055","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2217\/pme-2017-0078","article-title":"How genome editing could be used in the treatment of cardiovascular diseases","volume":"15","author":"Musunuru","year":"2018","journal-title":"Pers Med"},{"issue":"1","key":"10.1016\/bs.pmbts.2021.01.021_bb0060","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jacbts.2018.11.004","article-title":"Therapeutic genome editing in cardiovascular diseases","volume":"4","author":"German","year":"2019","journal-title":"JACC Basic Transl Sci"},{"issue":"5","key":"10.1016\/bs.pmbts.2021.01.021_bb0065","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1161\/HYPERTENSIONAHA.118.11175","article-title":"Attenuation of microbiotal dysbiosis and hypertension in a CRISPR\/Cas9 gene ablation rat model of GPER1","volume":"72","author":"Waghulde","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/bs.pmbts.2021.01.021_bb0070","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/bs.pmbts.2021.01.021_bb0075","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1701719","article-title":"Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease","volume":"377","author":"Jaiswal","year":"2017","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/bs.pmbts.2021.01.021_bb0080","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1182\/blood-2017-02-769869","article-title":"Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly","volume":"130","author":"Zink","year":"2017","journal-title":"Blood"},{"issue":"6327","key":"10.1016\/bs.pmbts.2021.01.021_bb0085","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1126\/science.aag1381","article-title":"Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice","volume":"355","author":"Fuster","year":"2017","journal-title":"Science"},{"issue":"12","key":"10.1016\/bs.pmbts.2021.01.021_bb0090","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1038\/nm.3733","article-title":"Age-related mutations associated with clonal hematopoietic expansion and malignancies","volume":"20","author":"Xie","year":"2014","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/bs.pmbts.2021.01.021_bb0095","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1161\/CIRCRESAHA.118.313225","article-title":"CRISPR-mediated gene editing to assess the roles of Tet2 and Dnmt3a in clonal hematopoiesis and cardiovascular disease","volume":"123","author":"Sano","year":"2018","journal-title":"Circ Res"},{"key":"10.1016\/bs.pmbts.2021.01.021_bb0100","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/ng1068","article-title":"DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells","volume":"33","author":"Marie-France","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/bs.pmbts.2021.01.021_bb0105","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/s41419-018-0495-z","article-title":"DNA methylation, through DNMT1, has an essential role in the development of gastrointestinal smooth muscle cells and disease","volume":"9","author":"Jorgensen","year":"2018","journal-title":"Cell Death Dis"},{"issue":"10","key":"10.1016\/bs.pmbts.2021.01.021_bb0110","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1101\/gad.2037511","article-title":"CpG islands and the regulation of transcription","volume":"25","author":"Deaton","year":"2011","journal-title":"Genes Dev"},{"issue":"3","key":"10.1016\/bs.pmbts.2021.01.021_bb0115","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/term.2800","article-title":"DNA methyltransferases inhibitors effectively induce gene expression changes suggestive of cardiomyogenic differentiation of human amniotic fluid-derived mesenchymal stem cells via chromatin remodeling","volume":"13","author":"Gasi\u016bnien\u0117","year":"2019","journal-title":"J Tissue Eng Regen Med"},{"issue":"7","key":"10.1016\/bs.pmbts.2021.01.021_bb0120","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/s41374-020-0402-y","article-title":"Myocardial tissue-specific Dnmt1 knockout in rats protects against pathological injury induced by Adriamycin","volume":"100","author":"Wu","year":"2020","journal-title":"Lab Invest"},{"issue":"1","key":"10.1016\/bs.pmbts.2021.01.021_bb0125","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/BF00281261","article-title":"A distinct osteochondrodysplasia with hypertrichosis individualization of a probable autosomal recessive entity","volume":"60","author":"Cant\u00fa","year":"1982","journal-title":"Hum Genet"},{"issue":"12","key":"10.1016\/bs.pmbts.2021.01.021_bb0130","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.ejmg.2013.09.009","article-title":"Mutation of KCNJ8 in a patient with Cant\u00fa syndrome with unique vascular abnormalities-support for the role of K(ATP) channels in this condition","volume":"56","author":"Brownstein","year":"2013","journal-title":"Eur J Med Genet"},{"issue":"15","key":"10.1016\/bs.pmbts.2021.01.021_bb0135","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1002\/ajmg.a.31348","article-title":"Cantu syndrome in a woman and her two daughters: further confirmation of autosomal dominant inheritance and review of the cardiac manifestations","volume":"140","author":"Grange","year":"2006","journal-title":"Am J Med Genet A"},{"issue":"3","key":"10.1016\/bs.pmbts.2021.01.021_bb0140","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1212\/WNL.0000000000002861","article-title":"Neurologic and neuroimaging manifestations of Cant\u00fa syndrome: a case series","volume":"87","author":"Leon Guerrero","year":"2016","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/bs.pmbts.2021.01.021_bb0145","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/ajmg.a.33885","article-title":"Cant\u00fa syndrome: report of nine new cases and expansion of the clinical phenotype","volume":"155A","author":"Scurr","year":"2011","journal-title":"Am J Med Genet A"},{"issue":"7","key":"10.1016\/bs.pmbts.2021.01.021_bb0150","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/humu.22555","article-title":"Cant\u00fa syndrome resulting from activating mutation in the KCNJ8 gene","volume":"35","author":"Cooper","year":"2014","journal-title":"Hum Mutat"},{"issue":"7","key":"10.1016\/bs.pmbts.2021.01.021_bb0155","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/ng.2324","article-title":"Dominant missense mutations in ABCC9 cause Cant\u00fa syndrome","volume":"44","author":"Harakalova","year":"2012","journal-title":"Nat Genet"},{"issue":"10","key":"10.1016\/bs.pmbts.2021.01.021_bb0160","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.035469","article-title":"Effective CRISPR\/Cas9-based nucleotide editing in zebrafish to model human genetic cardiovascular disorders","volume":"11","author":"Tessadori","year":"2018","journal-title":"Dis Model Mech"},{"issue":"15","key":"10.1016\/bs.pmbts.2021.01.021_bb0165","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.121153","article-title":"Cardiovascular consequences of KATP overactivity in Cantu syndrome","volume":"3","author":"Huang","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/bs.pmbts.2021.01.021_bb0170","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nature03940","article-title":"Mutations in NOTCH1 cause aortic valve disease","volume":"437","author":"Garg","year":"2005","journal-title":"Nature"},{"issue":"3","key":"10.1016\/bs.pmbts.2021.01.021_bb0175","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/CRD.0000000000000053","article-title":"Why does the bicuspid aortic valve keep eluding us?","volume":"24","author":"Itagaki","year":"2016","journal-title":"Cardiol Rev"},{"issue":"20","key":"10.1016\/bs.pmbts.2021.01.021_bb0180","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1056\/NEJMra1207059","article-title":"Aortic dilatation in patients with bicuspid aortic valve","volume":"370","author":"Verma","year":"2014","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/bs.pmbts.2021.01.021_bb0185","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.jtcvs.2018.02.087","article-title":"Induced pluripotent stem cells with NOTCH1 gene mutation show impaired differentiation into smooth muscle and endothelial cells: implications for bicuspid aortic valve-related aortopathy","volume":"156","author":"Jiao","year":"2018","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"1","key":"10.1016\/bs.pmbts.2021.01.021_bb0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2008.06.010","article-title":"Molecular basis of PCSK9 function","volume":"203","author":"Lambert","year":"2009","journal-title":"Atherosclerosis"},{"issue":"42","key":"10.1016\/bs.pmbts.2021.01.021_bb0195","doi-asserted-by":"crossref","first-page":"28856","DOI":"10.1074\/jbc.M109.037085","article-title":"Dissection of the endogenous cellular pathways of PCSK9-induced low density lipoprotein receptor degradation: evidence for an intracellular route","volume":"284","author":"Poirier","year":"2009","journal-title":"J Biol Chem"},{"issue":"17","key":"10.1016\/bs.pmbts.2021.01.021_bb0200","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.2174\/13816128113199990313","article-title":"Proprotein convertase subtilisin kexin 9 (PCSK9) inhibitors in the treatment of hypercholesterolemia and other pathologies","volume":"19","author":"Seidah","year":"2013","journal-title":"Curr Pharm Des"},{"issue":"12","key":"10.1016\/bs.pmbts.2021.01.021_bb0205","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1056\/NEJMoa054013","article-title":"Sequence variations in PCSK9, low LDL, and protection against coronary heart disease","volume":"354","author":"Cohen","year":"2006","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/bs.pmbts.2021.01.021_bb0210","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1161\/CIRCRESAHA.115.304351","article-title":"Permanent alteration of PCSK9 with in vivo CRISPR-Cas9 genome editing","volume":"115","author":"Ding","year":"2014","journal-title":"Circ Res"},{"issue":"7546","key":"10.1016\/bs.pmbts.2021.01.021_bb0215","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/nature14299","article-title":"In vivo genome editing using Staphylococcus aureus Cas9","volume":"520","author":"Ran","year":"2015","journal-title":"Nature"},{"issue":"5","key":"10.1016\/bs.pmbts.2021.01.021_bb0220","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1161\/ATVBAHA.116.307227","article-title":"CRISPR-Cas9 targeting of PCSK9 in human hepatocytes in vivo-brief report","volume":"36","author":"Wang","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/bs.pmbts.2021.01.021_bb0225","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"issue":"9","key":"10.1016\/bs.pmbts.2021.01.021_bb0230","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.molmed.2019.06.008","article-title":"CRISPR craze to transform cardiac biology","volume":"25","author":"van Kampen","year":"2019","journal-title":"Trends Mol Med"},{"key":"10.1016\/bs.pmbts.2021.01.021_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.scr.2019.101677","article-title":"Generation of a gene-corrected human induced pluripotent stem cell line derived from a patient with laterality defects and congenital heart anomalies with a c.455G>A alteration in DAND5","volume":"42","author":"In\u00e1cio","year":"2020","journal-title":"Stem Cell Res"},{"key":"10.1016\/bs.pmbts.2021.01.021_bb0240","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.stem.2016.07.006","article-title":"Transcriptome profiling of patient-specific human iPSC-cardiomyocytes predicts individual drug safety and efficacy responses in vitro","volume":"19","author":"Matsa","year":"2016","journal-title":"Cell Stem Cell"},{"key":"10.1016\/bs.pmbts.2021.01.021_bb0245","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1093\/eurheartj\/ehu274","volume":"35","author":"Cuchel","year":"2014","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/bs.pmbts.2021.01.021_bb0250","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/humu.1380010602","article-title":"Molecular genetics of the LDL receptor gene in familial hypercholesterolemia","volume":"1","author":"Hobbs","year":"1992","journal-title":"Hum Mutat"},{"key":"10.1016\/bs.pmbts.2021.01.021_bb0255","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/hep4.1110","article-title":"CRISPR correction of a homozygous low-density lipoprotein receptor mutation in familial hypercholesterolemia induced pluripotent stem cells","volume":"1","author":"Omer","year":"2017","journal-title":"Hepatol Commun"},{"issue":"1","key":"10.1016\/bs.pmbts.2021.01.021_bb0260","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1161\/CIRCULATIONAHA.119.042476","article-title":"In vivo AAV-CRISPR\/Cas9-mediated gene editing ameliorates atherosclerosis in familial hypercholesterolemia","volume":"141","author":"Zhao","year":"2020","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/bs.pmbts.2021.01.021_bb0265","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1093\/aje\/155.6.487","article-title":"Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review","volume":"155","author":"Eichner","year":"2002","journal-title":"Am J Epidemiol"},{"issue":"11","key":"10.1016\/bs.pmbts.2021.01.021_bb0270","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027037","article-title":"Biophysical analysis of apolipoprotein E3 variants linked with development of type III hyperlipoproteinemia","volume":"6","author":"Georgiadou","year":"2011","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/bs.pmbts.2021.01.021_bb0275","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.036632","article-title":"Apolipoprotein E deficiency accelerates atherosclerosis development in miniature pigs","volume":"11","author":"Fang","year":"2018","journal-title":"Dis Model Mech"},{"issue":"5","key":"10.1016\/bs.pmbts.2021.01.021_bb0280","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.cell.2013.02.022","article-title":"Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression","volume":"152","author":"Qi","year":"2013","journal-title":"Cell"},{"issue":"2","key":"10.1016\/bs.pmbts.2021.01.021_bb0285","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.cell.2013.06.044","article-title":"CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes","volume":"154","author":"Gilbert","year":"2013","journal-title":"Cell"},{"issue":"1","key":"10.1016\/bs.pmbts.2021.01.021_bb0290","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1242\/dev.103341","article-title":"Cas9 effector-mediated regulation of transcription and differentiation in human pluripotent stem cells","volume":"141","author":"Kearns","year":"2014","journal-title":"Development"},{"issue":"4","key":"10.1016\/bs.pmbts.2021.01.021_bb0295","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.stem.2016.01.022","article-title":"CRISPR interference efficiently induces specific and reversible gene silencing in human iPSCs","volume":"18","author":"Mandegar","year":"2016","journal-title":"Cell Stem Cell"},{"issue":"12","key":"10.1016\/bs.pmbts.2021.01.021_bb0300","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jacc.2015.01.019","article-title":"New perspectives on the prevalence of hypertrophic cardiomyopathy","volume":"65","author":"Semsarian","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/bs.pmbts.2021.01.021_bb0305","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/cvr\/cvv025","article-title":"Genetic advances in sarcomeric cardiomyopathies: state of the art","volume":"105","author":"Ho","year":"2015","journal-title":"Cardiovasc Res"},{"key":"10.1016\/bs.pmbts.2021.01.021_bb0310","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1161\/hc3701.095952","article-title":"Hypertrophic cardiomyopathy: histopathological features of sudden death in cardiac troponin T disease","volume":"104","author":"Varnava","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/bs.pmbts.2021.01.021_bb0315","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1056\/NEJM199504203321603","article-title":"Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy","volume":"332","author":"Watkins","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/bs.pmbts.2021.01.021_bb0320","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.yjmcc.2017.12.002","article-title":"Hypertrophic cardiomyopathy-linked mutation in troponin T causes myofibrillar disarray and pro-arrhythmic action potential changes in human iPSC cardiomyocytes","volume":"114","author":"Wang","year":"2018","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/bs.pmbts.2021.01.021_bb0325","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0092-8674(00)81878-4","article-title":"MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure","volume":"88","author":"Arber","year":"1997","journal-title":"Cell"},{"key":"10.1016\/bs.pmbts.2021.01.021_bb0330","doi-asserted-by":"crossref","first-page":"6046","DOI":"10.1128\/MCB.00654-09","article-title":"Muscle LIM protein interacts with cofilin 2 and regulates F-actin dynamics in cardiac and skeletal muscle","volume":"29","author":"Papalouka","year":"2009","journal-title":"Mol Cell Biol"},{"key":"10.1016\/bs.pmbts.2021.01.021_bb0335","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1161\/01.CIR.0000056522.82563.5F","article-title":"Mutations in the human muscle LIM protein gene in families with hypertrophic cardiomyopathy","volume":"107","author":"Geier","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/bs.pmbts.2021.01.021_bb0340","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1096-7192(03)00142-2","article-title":"Mutations in the muscle LIM protein and alpha-actinin-2 genes in dilated cardiomyopathy and endocardial fibroelastosis","volume":"80","author":"Mohapatra","year":"2003","journal-title":"Mol Genet Metab"},{"issue":"8","key":"10.1016\/bs.pmbts.2021.01.021_bb0345","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/s41419-019-1826-4","article-title":"MLP-deficient human pluripotent stem cell derived cardiomyocytes develop hypertrophic cardiomyopathy and heart failure phenotypes due to abnormal calcium handling","volume":"10","author":"Li","year":"2019","journal-title":"Cell Death Dis"},{"key":"10.1016\/bs.pmbts.2021.01.021_bb0350","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3389\/fphar.2016.00162","article-title":"Downregulation of GSTK1 is a common mechanism underlying hypertrophic cardiomyopathy","volume":"7","author":"Sasagawa","year":"2016","journal-title":"Front Pharmacol"},{"issue":"24","key":"10.1016\/bs.pmbts.2021.01.021_bb0355","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1056\/NEJM200506163522417","article-title":"Glycogen storage diseases and cardiomyopathy","volume":"352","author":"Roos","year":"2005","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/bs.pmbts.2021.01.021_bb0360","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJM199102073240607","article-title":"An atypical variant of Fabry's disease with manifestations confined to the myocardium","volume":"324","author":"von Scheidt","year":"1991","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/bs.pmbts.2021.01.021_bb0365","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3390\/cells8040327","article-title":"Generation of GLA-knockout human embryonic stem cell lines to model autophagic dysfunction and exosome secretion in fabry disease-associated hypertrophic cardiomyopathy","volume":"8","author":"Song","year":"2019","journal-title":"Cell"},{"key":"10.1016\/bs.pmbts.2021.01.021_bb0370","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1124\/pr.113.008268","article-title":"Transient receptor potential channels as drug targets: from the science of basic research to the art of medicine","volume":"66","author":"Nilius","year":"2014","journal-title":"Pharmacol Rev"},{"issue":"2","key":"10.1016\/bs.pmbts.2021.01.021_bb9005","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1161\/01.RES.0000233356.10630.8a","article-title":"Transient receptor potential channels in cardiovascular function and disease","volume":"99","author":"Inoue","year":"2006","journal-title":"Circ Res"},{"issue":"8","key":"10.1016\/bs.pmbts.2021.01.021_bb0375","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.bbadis.2007.02.007","article-title":"Involvement of transient receptor potential proteins in cardiac hypertrophy","volume":"1772","author":"Guinamard","year":"2007","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"10.1016\/bs.pmbts.2021.01.021_bb0380","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s00395-017-0643-0","article-title":"Long-term spironolactone treatment reduces coronary TRPC expression, vasoconstriction, and atherosclerosis in metabolic syndrome pigs","volume":"112","author":"Li","year":"2017","journal-title":"Basic Res Cardiol"},{"issue":"15","key":"10.1016\/bs.pmbts.2021.01.021_bb0385","doi-asserted-by":"crossref","first-page":"7000","DOI":"10.1073\/pnas.1001825107","article-title":"TRPC channels are necessary mediators of pathologic cardiac hypertrophy","volume":"107","author":"Wu","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/bs.pmbts.2021.01.021_bb0390","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.yjmcc.2006.10.020","article-title":"Upregulation of TRPC1 in the development of cardiac hypertrophy","volume":"42","author":"Ohba","year":"2007","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/bs.pmbts.2021.01.021_bb0395","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.yjmcc.2018.10.020","article-title":"Inhibition of TRPC1 prevents cardiac hypertrophy via NF-\u03baB signaling pathway in human pluripotent stem cell-derived cardiomyocytes","volume":"126","author":"Tang","year":"2019","journal-title":"J Mol Cell Cardiol"},{"issue":"9863","key":"10.1016\/bs.pmbts.2021.01.021_bb0400","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0140-6736(12)61023-X","article-title":"Noonan syndrome","volume":"381","author":"Roberts","year":"2013","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/bs.pmbts.2021.01.021_bb0405","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/MCD.0000000000000194","article-title":"RAF1 variants causing biventricular hypertrophic cardiomyopathy in two preterm infants: further phenotypic delineation and review of literature","volume":"26","author":"Thompson","year":"2017","journal-title":"Clin Dysmorphol"},{"issue":"3","key":"10.1016\/bs.pmbts.2021.01.021_bb0410","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1161\/CIRCULATIONAHA.118.037227","article-title":"Inducible pluripotent stem cell-derived cardiomyocytes reveal aberrant extracellular regulated kinase 5 and mitogen-activated protein kinase kinase 1\/2 signaling concomitantly promote hypertrophic cardiomyopathy in RAF1-associated Noonan syndrome","volume":"140","author":"Jaffr\u00e9","year":"2019","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/bs.pmbts.2021.01.021_bb0415","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1073\/pnas.1523918113","article-title":"A mouse model for adult cardiac-specific gene deletion with CRISPR\/Cas9","volume":"113","author":"Carroll","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/bs.pmbts.2021.01.021_bb0420","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1161\/01.cir.0000442015.53336.12","article-title":"Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association","volume":"129","author":"Go","year":"2014","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/bs.pmbts.2021.01.021_bb0425","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/nrcardio.2013.105","article-title":"Dilated cardiomyopathy: the complexity of a diverse genetic architecture","volume":"10","author":"Hershberger","year":"2013","journal-title":"Nat Rev Cardiol"},{"issue":"2","key":"10.1016\/bs.pmbts.2021.01.021_bb0430","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1086\/321978","article-title":"Many roads lead to a broken heart: the genetics of dilated cardiomyopathy","volume":"69","author":"Sch\u00f6nberger","year":"2001","journal-title":"Am J Hum Genet"},{"issue":"12","key":"10.1016\/bs.pmbts.2021.01.021_bb0435","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1161\/CIRCRESAHA.111.259754","article-title":"Modulation of cardiac contractility by the phospholamban\/SERCA2a regulatome","volume":"110","author":"Kranias","year":"2012","journal-title":"Circ Res"},{"key":"10.1016\/bs.pmbts.2021.01.021_bb0440","doi-asserted-by":"crossref","first-page":"6955","DOI":"10.1038\/ncomms7955","article-title":"Correction of human phospholamban R14del mutation associated with cardiomyopathy using targeted nucleases and combination therapy","volume":"6","author":"Karakikes","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/bs.pmbts.2021.01.021_bb0445","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1126\/science.1081578","article-title":"Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban","volume":"299","author":"Schmitt","year":"2003","journal-title":"Science"},{"key":"10.1016\/bs.pmbts.2021.01.021_bb0450","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s12471-013-0413-z","article-title":"The phospholamban p.Arg14del founder mutation in Dutch patients with arrhythmogenic cardiomyopathy","volume":"21","author":"van der Heijden","year":"2013","journal-title":"Neth Heare J"},{"key":"10.1016\/bs.pmbts.2021.01.021_bb0455","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.yjmcc.2018.05.007","article-title":"Functional and transcriptomic insights into pathogenesis of R9C phospholamban mutation using human induced pluripotent stem cell-derived cardiomyocytes","volume":"119","author":"Ceholski","year":"2018","journal-title":"J Mol Cell Cardiol"},{"issue":"3","key":"10.1016\/bs.pmbts.2021.01.021_bb0460","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1172\/JCI0214571","article-title":"Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy","volume":"109","author":"Arad","year":"2002","journal-title":"J Clin Invest"},{"issue":"11","key":"10.1016\/bs.pmbts.2021.01.021_bb0465","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/hmg\/10.11.1215","article-title":"Mutations in the gamma(2) subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis","volume":"10","author":"Blair","year":"2001","journal-title":"Hum Mol Genet"},{"issue":"3","key":"10.1016\/bs.pmbts.2021.01.021_bb0470","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/00001573-200205000-00004","article-title":"PRKAG2 cardiac syndrome: familial ventricular preexcitation, conduction system disease, and cardiac hypertrophy","volume":"17","author":"Gollob","year":"2002","journal-title":"Curr Opin Cardiol"},{"issue":"10","key":"10.1016\/bs.pmbts.2021.01.021_bb0475","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/cr.2016.101","article-title":"Genome editing with CRISPR\/Cas9 in postnatal mice corrects PRKAG2 cardiac syndrome","volume":"26","author":"Xie","year":"2016","journal-title":"Cell Res"},{"key":"10.1016\/bs.pmbts.2021.01.021_bb0480","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.yjmcc.2018.02.007","article-title":"Establishment of a PRKAG2 cardiac syndrome disease model and mechanism study using human induced pluripotent stem cells","volume":"117","author":"Zhan","year":"2018","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/bs.pmbts.2021.01.021_bb0485","doi-asserted-by":"crossref","first-page":"5288","DOI":"10.1038\/ncomms6288","article-title":"Dynamic DNA methylation orchestrates cardiomyocyte development, maturation and disease","volume":"5","author":"Gilsbach","year":"2014","journal-title":"Nat Commun"},{"issue":"16","key":"10.1016\/bs.pmbts.2021.01.021_bb0490","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1161\/CIRCULATIONAHA.117.029840","article-title":"DNA methylation and human heart failure: mechanisms or prognostics","volume":"136","author":"Rau","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/bs.pmbts.2021.01.021_bb0495","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.yjmcc.2018.05.012","article-title":"Pharmacological inhibition of DNA methylation attenuates pressure overload-induced cardiac hypertrophy in rats","volume":"120","author":"Stenzig","year":"2018","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/bs.pmbts.2021.01.021_bb0500","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.yjmcc.2018.05.012","article-title":"Pharmacological inhibition of DNA methylation attenuates pressure overload-induced cardiac hypertrophy in rats","volume":"120","author":"Stenzig","year":"2018","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/bs.pmbts.2021.01.021_bb0505","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/cvr\/cvt264","article-title":"Inhibition of DNA methylation reverses norepinephrine-induced cardiac hypertrophy in rats","volume":"101","author":"Daliao","year":"2014","journal-title":"Cardiovasc Res"},{"issue":"7","key":"10.1016\/bs.pmbts.2021.01.021_bb0510","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1161\/CIRCRESAHA.117.309345","article-title":"Arrhythmogenic cardiomyopathy","volume":"121","author":"Corrado","year":"2017","journal-title":"Circ Res"},{"issue":"2","key":"10.1016\/bs.pmbts.2021.01.021_bb0515","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ijcard.2010.12.051","article-title":"Cardiac ion channel mutations in the sudden infant death syndrome","volume":"152","author":"Klaver","year":"2011","journal-title":"Int J Cardiol"},{"key":"10.1016\/bs.pmbts.2021.01.021_bb0520","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nrcardio.2009.44","article-title":"Sodium channel mutations and arrhythmias","volume":"6","author":"Ruan","year":"2009","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/bs.pmbts.2021.01.021_bb0525","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1093\/hmg\/4.9.1603","article-title":"Cardiac sodium channel mutations in patients with long QT syndrome, an inherited cardiac arrhythmia","volume":"4","author":"Wang","year":"1995","journal-title":"Hum Mol Genet"},{"issue":"12","key":"10.1016\/bs.pmbts.2021.01.021_bb0530","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.acvd.2013.08.003","article-title":"Brugada syndrome and abnormal splicing of SCN5A in myotonic dystrophy type 1","volume":"106","author":"Wahbi","year":"2013","journal-title":"Arch Cardiovasc Dis"},{"issue":"19","key":"10.1016\/bs.pmbts.2021.01.021_bb0535","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.010393","article-title":"CRISPR-mediated expression of the fetal Scn5a isoform in adult mice causes conduction defects and arrhythmias","volume":"7","author":"Pang","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/bs.pmbts.2021.01.021_bb0540","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/HCO.0b013e32835f0c79","article-title":"\u2018State-of-the-heart\u2019 of cardiac laminopathies","volume":"28","author":"Cattin","year":"2013","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/bs.pmbts.2021.01.021_bb0545","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1101\/gad.1652708","article-title":"Nuclear lamins: major factors in the structural organization and function of the nucleus and chromatin","volume":"22","author":"Dechat","year":"2008","journal-title":"Genes Dev"},{"issue":"1","key":"10.1016\/bs.pmbts.2021.01.021_bb0550","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1038\/s41467-019-09929-w","article-title":"The K219T-Lamin mutation induces conduction defects through epigenetic inhibition of SCN5A in human cardiac laminopathy","volume":"10","author":"Salvarani","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/bs.pmbts.2021.01.021_bb0555","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/B978-0-12-387786-4.00008-7","article-title":"Transcription factor pathways and congenital heart disease","volume":"100","author":"McCulley","year":"2012","journal-title":"Curr Top Dev Biol"},{"issue":"6","key":"10.1016\/bs.pmbts.2021.01.021_bb0560","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1161\/CIRCRESAHA.116.309140","article-title":"Genetics and genomics of congenital heart disease","volume":"120","author":"Zaidi","year":"2017","journal-title":"Circ Res"},{"issue":"4","key":"10.1016\/bs.pmbts.2021.01.021_bb0565","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1161\/CIRCRESAHA.112.300853","article-title":"Genetics of congenital heart disease: the glass half empty","volume":"112","author":"Fahed","year":"2013","journal-title":"Circ Res"},{"issue":"7616","key":"10.1016\/bs.pmbts.2021.01.021_bb0570","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nature19057","article-title":"Analysis of protein-coding genetic variation in 60,706 humans","volume":"536","author":"Lek","year":"2016","journal-title":"Nature"},{"issue":"5","key":"10.1016\/bs.pmbts.2021.01.021_bb0575","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"issue":"3","key":"10.1016\/bs.pmbts.2021.01.021_bb0580","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ajhg.2017.07.014","article-title":"Variant interpretation: functional assays to the rescue","volume":"101","author":"Starita","year":"2017","journal-title":"Am J Hum Genet"},{"issue":"9975","key":"10.1016\/bs.pmbts.2021.01.021_bb0585","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/S0140-6736(14)61705-0","article-title":"Genetic diagnosis of developmental disorders in the DDD study: a scalable analysis of genome-wide research data","volume":"385","author":"Wright","year":"2015","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/bs.pmbts.2021.01.021_bb0590","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ejmg.2012.02.002","article-title":"Non-synonymous variants in pre-B cell leukemia homeobox (PBX) genes are associated with congenital heart defects","volume":"55","author":"Arrington","year":"2012","journal-title":"Eur J Med Genet"},{"issue":"4","key":"10.1016\/bs.pmbts.2021.01.021_bb0595","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3390\/jdb3040093","article-title":"Pbx4 is required for the temporal onset of zebrafish myocardial differentiation","volume":"3","author":"Kao","year":"2015","journal-title":"J Dev Biol"},{"issue":"7","key":"10.1016\/bs.pmbts.2021.01.021_bb0600","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1161\/CIRCRESAHA.108.175489","article-title":"Pbx\/Meis deficiencies demonstrate multigenetic origins of congenital heart disease","volume":"103","author":"Stankunas","year":"2008","journal-title":"Circ Res"},{"issue":"10","key":"10.1016\/bs.pmbts.2021.01.021_bb0605","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.035972","article-title":"Functional testing of a human PBX3 variant in zebrafish reveals a potential modifier role in congenital heart defects","volume":"11","author":"Farr","year":"2018","journal-title":"Dis Model Mech"},{"issue":"11","key":"10.1016\/bs.pmbts.2021.01.021_bb0610","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s13238-018-0560-5","article-title":"CRISPR\/Cas9-mediated gene knockout reveals a guardian role of NF-\u03baB\/RelA in maintaining the homeostasis of human vascular cells","volume":"9","author":"Wang","year":"2018","journal-title":"Protein Cell"},{"key":"10.1016\/bs.pmbts.2021.01.021_bb0615","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/sj.cdd.4401838","article-title":"Good cop, bad cop: the different faces of NF-kappaB","volume":"13","author":"Perkins","year":"2006","journal-title":"Cell Death Differ"},{"key":"10.1016\/bs.pmbts.2021.01.021_bb0620","first-page":"449","article-title":"NFkappaB in aging and disease","volume":"2","author":"Tilstra","year":"2011","journal-title":"Aging Dis"}],"container-title":["Progress in Molecular Biology and Translational Science","Reprogramming the Genome: CRISPR-Cas-based Human Disease Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877117321000326?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877117321000326?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T11:19:00Z","timestamp":1753355940000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877117321000326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"ISBN":["9780323853231"],"references-count":125,"URL":"https:\/\/doi.org\/10.1016\/bs.pmbts.2021.01.021","relation":{},"ISSN":["1877-1173"],"issn-type":[{"type":"print","value":"1877-1173"}],"subject":[],"published":{"date-parts":[[2021]]}}}